相似文献
1
Intravenous to Oral Switch in Complicated Staphylococcus aureus Bacteremia Without Endovascular Infection: A Retrospective Single-Center Cohort Study.
Clin Infect Dis. 2021 Sep 7;73(5):895-898. doi: 10.1093/cid/ciab156.
2
F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Bacteremia: A Proof of Principle.
J Nucl Med. 2019 Jul;60(7):998-1002. doi: 10.2967/jnumed.118.221929. Epub 2018 Dec 14.
3
Individualizing the use of [F]FDG-PET/CT in patients with complicated Staphylococcus aureus bacteremia: experiences from a tertiary care center.
Infection. 2022 Apr;50(2):491-498. doi: 10.1007/s15010-021-01740-4. Epub 2021 Dec 20.
4
The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
Int J Infect Dis. 2021 Jan;102:554-560. doi: 10.1016/j.ijid.2020.10.097. Epub 2020 Nov 4.
5
Impact of [F] FDG PET/CT on outcomes in patients with Staphylococcus aureus bacteremia: A retrospective single-center experience.
Infect Dis Now. 2024 Oct;54(7):104977. doi: 10.1016/j.idnow.2024.104977. Epub 2024 Sep 12.
6
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
Clin Infect Dis. 2024 Oct 15;79(4):871-887. doi: 10.1093/cid/ciad666.
7
Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.
Clin Infect Dis. 2022 Oct 12;75(8):1457-1461. doi: 10.1093/cid/ciac363.
8
Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial.
Trials. 2015 Oct 9;16:450. doi: 10.1186/s13063-015-0973-x.
9
F-FDG PET/CT Optimizes Treatment in Bacteremia and Is Associated with Reduced Mortality.
J Nucl Med. 2017 Sep;58(9):1504-1510. doi: 10.2967/jnumed.117.191981. Epub 2017 Mar 23.
10
Early Oral Switch to Linezolid for Low-risk Patients With Staphylococcus aureus Bloodstream Infections: A Propensity-matched Cohort Study.
Clin Infect Dis. 2019 Jul 18;69(3):381-387. doi: 10.1093/cid/ciy916.
引用本文的文献
1
The role of [18F]FDG-PET/CT in Staphylococcus aureus bacteremia: A clinical perspective.
Npj Imaging. 2024 Sep 13;2(1):32. doi: 10.1038/s44303-024-00036-0.
2
Transitioning to oral therapy compared to IV in bloodstream infections: a systematic review and meta-analysis.
Ann Med Surg (Lond). 2025 Jan 9;87(1):265-275. doi: 10.1097/MS9.0000000000002742. eCollection 2025 Jan.
3
Treatment of Complicated Gram-Positive Bacteremia and Infective Endocarditis.
Drugs. 2025 Feb;85(2):193-214. doi: 10.1007/s40265-024-02135-z. Epub 2024 Dec 25.
4
Clinical Outcomes of Oral Antibiotic Switch in Children with Staphylococcus aureus Bacteremia.
Turk Arch Pediatr. 2024 Sep 2;59(5):469-475. doi: 10.5152/TurkArchPediatr.2024.24108.
5
Genetic Testing Technology Assisting in the Diagnosis and Treatment of Multiple Suppurative Arthritis and Extensive Migratory Skin and Soft Tissue Infections Caused by Disseminated Staphylococcus aureus Disease: A Case Report and Review.
Infect Drug Resist. 2024 Sep 25;17:4185-4194. doi: 10.2147/IDR.S479043. eCollection 2024.
6
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
Clin Infect Dis. 2024 Oct 15;79(4):871-887. doi: 10.1093/cid/ciad666.
7
Rifampin Based Therapy for Patients With Staphylococcus aureus Native Vertebral Osteomyelitis: A Systematic Review and Meta-analysis.
Clin Infect Dis. 2024 Jan 25;78(1):40-47. doi: 10.1093/cid/ciad560.
8
Evaluation of the microbiota-sparing properties of the anti-staphylococcal antibiotic afabicin.
J Antimicrob Chemother. 2023 Aug 2;78(8):1900-1908. doi: 10.1093/jac/dkad181.
9
Comparison of Oral and Intravenous Definitive Antibiotic Therapy for Beta-Hemolytic Streptococcus Species Bloodstream Infections from Soft Tissue Sources: a Propensity Score-Matched Analysis.
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0012023. doi: 10.1128/aac.00120-23. Epub 2023 May 16.
10
[F]FDG-PET/CT in patients with bacteremia: Clinical impact on patient management and outcome.
Front Med (Lausanne). 2023 Mar 29;10:1157692. doi: 10.3389/fmed.2023.1157692. eCollection 2023.
Zotero 插件